Exploring drug-target interaction networks of illicit drugs

BMC Genomics

Volumn 14, Issue , 2013, Pages

  Atreya, Ravi V ^a   Sun, Jingchun ^a   Zhao, Zhongming ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; CENTRAL STIMULANT AGENT; ILLICIT DRUG; OPIATE; STEROID; CENTRAL DEPRESSANT AGENT; PROTEIN; STREET DRUG;

ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG REPOSITIONING; DRUG TARGETING; HEALTH CARE SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; MOLECULAR MECHANICS; POLYPHARMACOLOGY; ADDICTION; BIOLOGY; DRUG DATABASE; GENE; GENE ONTOLOGY; GENETICS; METABOLISM; METHODOLOGY; REVIEW; UNITED STATES;

ANALGESICS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CENTRAL NERVOUS SYSTEM STIMULANTS; COMPUTATIONAL BIOLOGY; DATABASES, PHARMACEUTICAL; GENE ONTOLOGY; GENES; HUMANS; PROTEINS; STEROIDS; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 84903853803     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-14-S4-S1     Document Type: Article

References (50)

1. Chipman ML: Risk factors for injury: Similarities and differences for traffic crashes and other causes. Accid Anal Prev 1995, 27:699-706
2. Vitale S, van de Mheen D: Illicit drug use and injuries: A review of emergency room studies. Drug Alcohol Depend 2006, 82:1-9
3. Cherpitel CJ: Drinking patterns and problems, drug use and health services utilization: a comparison of two regions in the US general population. Drug Alcohol Depend 1999, 53:231-237
4. Volavka J, Citrome L: Pathways to aggression in schizophrenia affect results of treatment. Schizophr Bull 2011, 37:921-929
5. Li MD, Burmeister M: New insights into the genetics of addiction. Nat Rev Genet 2009, 10:225-231
6. Sun J, Zhao Z: Functional features, biological pathways, and protein interaction networks of addiction-related genes. Chem Biodivers 2010, 7:1153-1162
7. Sun J, Jia P, Fanous AH, Van den Oord E, Chen X, Riley BP, Amdur RL, Kendler KS, Zhao Z: Schizophrenia gene networks and pathways and their applications for novel candidate gene selection. PLoS ONE 2010, 5:e11351
8. Agrawal A, Lynskey MT, Bucholz KK, Martin NG, Madden PAF, Heath AC: Contrasting models of genetic co-morbidity for cannabis and other illicit drugs in adult Australian twins. Psychol Med 2007, 37:49-60
9. Agrawal A, Lynskey MT: The genetic epidemiology of cannabis use, abuse and dependence. Addiction 2006, 101:801-812
10. Li C-Y, Zhou W-Z, Zhang P-W, Johnson C, Wei L, Uhl GR: Meta-analysis and genome-wide interpretation of genetic susceptibility to drug addiction. BMC Genomics 2011, 12:508
11. Li C-Y, Mao X, Wei L: Genes and (common) pathways underlying drug addiction. PLoS Comput Biol 2008, 4:e2
12. Heidbreder CA, Hagan JJ: Novel pharmacotherapeutic approaches for the treatment of drug addiction and craving. Curr Opin Pharmacol 2005, 5:107-118
13. Hopkins AL: Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 2008, 4:682-690
14. Arrell DK, Terzic A: Network systems biology for drug discovery. Clin Pharmacol Ther 2010, 88:120-125
15. Berger SI, Iyengar R: Network analyses in systems pharmacology. Bioinformatics 2009, 25:2466-2472
16. Barabási A-L, Gulbahce N, Loscalzo J: Network medicine: a network-based approach to human disease. Nat Rev Genet 2011, 12:56-68
17. Michel Espinoza-Fonseca L: Knowledgebase for addiction-related genes: Is it possible an extrapolation to rational multi-target drug design? Bioorg Med Chem 2008, 16:9346-9348
18. Huang L-C, Chen JY: A network biology approach to predicting drug cardiotoxicity. 2011 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) 2011, 278-281
19. Putnam DK, Sun J, Zhao Z: Exploring schizophrenia drug-gene interactions through molecular network and pathway modeling. AMIA Annu Symp Proc 2011, 2011:1127-1133
20. Sun J, Wu Y, Xu H, Zhao Z: DTome: a web-based tool for drug-target interactome construction. BMC Bioinformatics 2012, 13:S7
21. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS: DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs. Nucleic Acids Res 2010, 39:D1035-1041
22. Wishart DS: DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 2006, 34:D668-672
23. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M: DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 2007, 36:D901-906
24. Atreya RV, Sun J, Zhao Z: A network and functional investigation of illicit drugs and their targets. Bioinformatics and Biomedicine Workshops (BIBMW), 2012 IEEE International Conference on: 4-7 October 2012 2012, 564-569
25. DrugBank. [http://www.drugbank.ca/]
26. The UniProt Consortium: Update on activities at the Universal Protein Resource (UniProt) in 2013. Nucleic Acids Res 2013, 41:D43-47
27. World Health Organization (WHO): The Anatomical Therapeutic Chemical Classification System. Oslo; 2003
28. Zhang B, Kirov S, Snoddy J: WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 2005, 33:W741-748
29. Benjamini Y, Yekutieli D: The control of the false discovery rate in multiple testing under dependency. Ann Statist 2001, 29:1165-1188
30. Barabási A-L, Oltvai ZN: Network biology: understanding the cell's functional organization. Nat Rev Genet 2004, 5:101-113
31. Taylor IW, Linding R, Warde-Farley D, Liu Y, Pesquita C, Faria D, Bull S, Pawson T, Morris Q, Wrana JL: Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat Biotechnol 2009, 27:199-204
32. Chen S-H, Chin C-H, Wu H-H, Ho C-W, Ko M-T, Lin C-Y: cyto-Hubba: A Cytoscape plug-in for hub object analysis in network biology. 20th International Conference on Genome Informatics 2009
33. Smoot ME, Ono K, Ruscheinski J, Wang P-L, Ideker T: Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 2011, 27:431-432
34. Yildirim MA, Goh K-I, Cusick ME, Barabási A-L, Vidal M: Drug-target network. Nat Biotechnol 2007, 25:1119-1126
35. Pujol A, Mosca R, Farrés J, Aloy P: Unveiling the role of network and systems biology in drug discovery. Trends Pharmacol Sci 2010, 31:115-123
36. Clarke SFJ, Dargan PI, Jones AL: Naloxone in opioid poisoning: walking the tightrope. Emerg Med J 2005, 22:612-616
37. Van Dorp ELA, Yassen A, Dahan A: Naloxone treatment in opioid addiction: the risks and benefits. Expert Opin Drug Saf 2007, 6:125-132
38. Frankel PS, Alburges ME, Bush L, Hanson GR, Kish SJ: Striatal and ventral pallidum dynorphin concentrations are markedly increased in human chronic cocaine users. Neuropharmacology 2008, 55:41-46
39. Prisinzano TE, Tidgewell K, Harding WW: Kappa Opioids as potential treatments for stimulant dependence. AAPS J 2005, 7:E592-599
40. Hasebe K, Kawai K, Suzuki T, Kawamura K, Tanaka T, Narita M, Nagase H, Suzuki T: Possible pharmacotherapy of the opioid ? receptor agonist for drug dependence. Ann NY Acad Sci 2004, 1025:404-413
41. Ambroggi F, Turiault M, Milet A, Deroche-Gamonet V, Parnaudeau S, Balado E, Barik J, van der Veen R, Maroteaux G, Lemberger T, Schütz G, Lazar M, Marinelli M, Piazza PV, Tronche F: Stress and addiction: glucocorticoid receptor in dopaminoceptive neurons facilitates cocaine seeking. Nat Neurosci 2009, 12:247-249
42. Desrivières S, Lourdusamy A, Müller C, Ducci F, Wong CP, Kaakinen M, Pouta A, Hartikainen A-L, Isohanni M, Charoen P, Peltonen L, Freimer N, Elliott P, Jarvelin M-R, Schumann G: Glucocorticoid receptor (NR3C1) gene polymorphisms and onset of alcohol abuse in adolescents. Addict Biol 2011, 16:510-513
43. Brackins T, Brahm NC, Kissack JC: Treatments for methamphetamine abuse: a literature review for the clinician. J Pharm Pract 2011, 24:541-550
44. Vergne DE, Anton RF: Aripiprazole: a drug with a novel mechanism of action and possible efficacy for alcohol dependence. CNS Neurol Disord Drug Targets 2010, 9:50-54
45. Gorelick DA, Wilkins JN: Bromocriptine treatment for cocaine addiction: association with plasma prolactin levels. Drug Alcohol Depend 2006, 81:189-195
46. Günther S, Kuhn M, Dunkel M, Campillos M, Senger C, Petsalaki E, Ahmed J, Urdiales EG, Gewiess A, Jensen LJ, Schneider R, Skoblo R, Russell RB, Bourne PE, Bork P, Preissner R: SuperTarget and Matador: resources for exploring drug-target relationships. Nucleic Acids Res 2008, 36:D919-922
47. Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res 2002, 30:412-415
48. Zhu F, Han B, Kumar P, Liu X, Ma X, Wei X, Huang L, Guo Y, Han L, Zheng C, Chen Y: Update of TTD: Therapeutic Target Database. Nucleic Acids Res 2010, 38:D787-791
49. Zheng S, Zhao Z: GenRev: exploring functional relevance of genes in molecular networks. Genomics 2012, 99:183-188
50. Beyer A, Bandyopadhyay S, Ideker T: Integrating physical and genetic maps: from genomes to interaction networks. Nat Rev Genet 2007, 8:699-710